The use of micro-costing in an economic analysis of allogeneic HSCT in Brazil

Authors

  • Dora Vargas Social Responsibility PROADI-SUS, Hospital Moinhos de Vento, Porto Alegre, RS, Brazil.
  • Caroline David Social Responsibility PROADI-SUS, Hospital Moinhos de Vento, Porto Alegre, RS, Brazil.
  • Jaqueline Horvath Social Responsibility PROADI-SUS, Hospital Moinhos de Vento, Porto Alegre, RS, Brazil.
  • Tatiana Silva Social Responsibility PROADI-SUS, Hospital Moinhos de Vento, Porto Alegre, RS, Brazil.
  • Mariana Pereira Social Responsibility PROADI-SUS, Hospital Moinhos de Vento, Porto Alegre, RS, Brazil.
  • Lisandra Rigoni Social Responsibility PROADI-SUS, Hospital Moinhos de Vento; Oncology Service, Hospital Moinhos de Vento; Hematology Service, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil
  • Ivaine Sartor Social Responsibility PROADI-SUS, Hospital Moinhos de Vento, Porto Alegre, RS, Brazil.
  • Gabriela Zavaglia Social Responsibility PROADI-SUS, Hospital Moinhos de Vento, Porto Alegre, RS, Brazil.
  • Luciane Kern Social Responsibility PROADI-SUS, Hospital Moinhos de Vento, Porto Alegre, RS, Brazil.
  • Thainá Luft Social Responsibility PROADI-SUS, Hospital Moinhos de Vento, Porto Alegre, RS, Brazil.
  • Fernanda Tolves Social Responsibility PROADI-SUS, Hospital Moinhos de Vento, Porto Alegre, RS, Brazil.
  • Fernanda Scherer Social Responsibility PROADI-SUS, Hospital Moinhos de Vento; Hematology Service, Hospital de Clínicas de Porto Alegre; Pediatric Service, Hospital Moinhos de Vento, Porto Alegre, RS, Brazil.
  • Jaina Pereira Social Responsibility PROADI-SUS, Hospital Moinhos de Vento. Porto Alegre, RS, Brazil.
  • Fabiano Barrionuevo Social Responsibility PROADI-SUS, Hospital Moinhos de Vento. Porto Alegre, RS, Brazil.
  • Ana Paula Etges National Health Technology Assessment Institute, CNPq, Porto Alegre, RS, Brazil
  • Bruna Zanotto National Health Technology Assessment Institute, CNPq, Porto Alegre, RS, Brazil
  • Liane Daudt Hematology Service, Hospital de Clínicas de Porto Alegre; Pediatric Service, Hospital Moinhos de Vento; School of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
  • Luciane Cruz Social Responsibility PROADI-SUS, Hospital Moinhos de Vento; National Health Technology Assessment Institute, CNPq, Porto Alegre, RS, Brazil.
  • Carisi Polanczyk National Health Technology Assessment Institute, CNPq; School of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
  • Claudia Astigarraga Oncology Service, Hospital Moinhos de Vento; Hematology Service, Hospital de Clínicas de Porto Alegre; School of Medicine, Universidade Federal do Rio Grande do Sul

DOI:

https://doi.org/10.21115/JBES.v13.n2.p166-74

Keywords:

micro-costing, TDABC, cost analysis, hematopoietic stem cell transplantation

Abstract

Objective: The objective of this study was to estimate treatment costs of Hematopoietic stem cell transplantation (HSCT) at a reference center in Brazil. Methods: The study population consisted of patients from the Unified Health System HSCT who underwent HSCT in southern Brazil between 2016 and 2019. Costs were measured using a micro-costing approach, based on Time-Driven Activity-based Costing (TDABC) adapted for economic studies in health and included the following steps: definition of the research question, structured data collection, and statistical analysis of results. Results: The total cost of HSCT was $155,110 ($92,794 – $249,146 USD). Matched unrelated donor HSCT was more expensive than matched related donor HSCT. The major cost factors involve post-transplant complications, mainly the occurrence of infections. Concerning cost composition, exams and procedures represent the largest expense in HSCT (45%). Conclusion: These estimates could be applicable to further evaluations for HSCT cost-effectiveness and help healthcare decision-makers in middle-income countries.

Downloads

Download data is not yet available.

Downloads

Published

2021-08-20

How to Cite

Vargas, D., David, C., Horvath, J., Silva, T., Pereira, M., Rigoni, L., … Astigarraga, C. (2021). The use of micro-costing in an economic analysis of allogeneic HSCT in Brazil . Jornal Brasileiro De Economia Da Saúde, 13(2), 166–174. https://doi.org/10.21115/JBES.v13.n2.p166-74

Issue

Vol. 13 No. 2 (2021)

Section

Artigos